Abstract:Accurate identification of potential drug-target pairs is a crucial step in drug development and drug repositioning, which is characterized by the ability of the drug to bind to and modulate the activity of the target molecule, resulting in the desired therapeutic effect. As machine learning and deep learning technologies advance, an increasing number of models are being engaged for the prediction of drug-target interactions. However, there is still a great challenge to improve the accuracy and efficiency of predicting. In this study, we proposed a deep learning method called Multi-source Information Fusion and Attention Mechanism for Drug-Target Interaction (MIFAM-DTI) to predict drug-target interactions. Firstly, the physicochemical property feature vector and the Molecular ACCess System molecular fingerprint feature vector of a drug were extracted based on its SMILES sequence. The dipeptide composition feature vector and the Evolutionary Scale Modeling -1b feature vector of a target were constructed based on its amino acid sequence information. Secondly, the PCA method was employed to reduce the dimensionality of the four feature vectors, and the adjacency matrices were constructed by calculating the cosine similarity. Thirdly, the two feature vectors of each drug were concatenated and the two adjacency matrices were subjected to a logical OR operation. And then they were fed into a model composed of graph attention network and multi-head self-attention to obtain the final drug feature vectors. With the same method, the final target feature vectors were obtained. Finally, these final feature vectors were concatenated, which served as the input to a fully connected layer, resulting in the prediction output. MIFAM-DTI not only integrated multi-source information to capture the drug and target features more comprehensively, but also utilized the graph attention network and multi-head self-attention to autonomously learn attention weights and more comprehensively capture information in sequence data. Experimental results demonstrated that MIFAM-DTI outperformed state-of-the-art methods in terms of AUC and AUPR. Case study results of coenzymes involved in cellular energy metabolism also demonstrated the effectiveness and practicality of MIFAM-DTI. The source code and experimental data for MIFAM-DTI are available at https://github.com/Search-AB/MIFAM-DTI.

MFF-DTA: Multi-scale Feature Fusion for Drug-Target Affinity Prediction

MFFDTA: A Multimodal Feature Fusion Framework for Drug-Target Affinity Prediction

Prediction of drug-target binding affinity based on multi-scale feature fusion

MMDTA: A Multimodal Deep Model for Drug-Target Affinity with a Hybrid Fusion Strategy

FusionDTA: attention-based feature polymerizer and knowledge distillation for drug-target binding affinity prediction

DeepFusionDTA: drug-target binding affinity prediction with information fusion and hybrid deep-learning ensemble model

MIFAM-DTI: a drug-target interactions predicting model based on multi-source information fusion and attention mechanism

MFA-DTI: Drug-target interaction prediction based on multi-feature fusion adopted framework

Multimodal contrastive representation learning for drug-target binding affinity prediction

MMD-DTA: A multi-modal deep learning framework for drug-target binding affinity and binding region prediction

Predicting Drug-Target Affinity by Learning Protein Knowledge From Biological Networks

MFR-DTA: a multi-functional and robust model for predicting drug–target binding affinity and region

MSGNN-DTA: Multi-Scale Topological Feature Fusion Based on Graph Neural Networks for Drug–Target Binding Affinity Prediction

DataDTA: a multi-feature and dual-interaction aggregation framework for drug–target binding affinity prediction

DFDTA-MultiAtt: Multi-attention based deep learning ensemble fusion network for drug target affinity prediction

SubMDTA: drug target affinity prediction based on substructure extraction and multi-scale features

AttentionMGT-DTA: A multi-modal drug-target affinity prediction using graph transformer and attention mechanism

GEFormerDTA: drug target affinity prediction based on transformer graph for early fusion

Improving drug-target affinity prediction via feature fusion and knowledge distillation

FusionDTI: Fine-grained Binding Discovery with Token-level Fusion for Drug-Target Interaction

GTAMP-DTA: Graph transformer combined with attention mechanism for drug-target binding affinity prediction